This BiTE significantly reduced tumor burden in a B16-OVA mouse melanoma model through activation of CD8+ T cells, as well as modulation of the tumor microenvironment by downregulating myeloid-derived suppressor cells and tumor-associated macrophages (109). This evidence concerns the gene CD8A and neoplasm.